Stockscreener 앱 받기
21.54
9.84%
1.93
Sanara Medtech Inc 주식(SMTI)의 최신 뉴스
Sanara MedTech (SMTI) Receives Updated Analyst Rating and Price Target | SMTI Stock News - GuruFocus
Can Sanara MedTech Inc. stock rebound after recent weaknessTrade Volume Report & Free Technical Confirmation Trade Alerts - newser.com
Is Sanara MedTech Inc. stock gaining market shareMarket Activity Report & Target Return Focused Stock Picks - newser.com
HC Wainwright & Co. Maintains Sanara MedTech (SMTI) Buy Recommendation - Nasdaq
Can Sanara MedTech Inc. stock sustain revenue growthMarket Movers & Fast Exit Strategy with Risk Control - newser.com
Best data tools to analyze Sanara MedTech Inc. stockTrade Risk Report & AI Based Buy and Sell Signals - newser.com
Sanara MedTech Hits 52-Week Low at USD 21.07 Amid Ongoing Struggles - Markets Mojo
How strong is Sanara MedTech Inc. stock revenue growthJuly 2025 Movers & Real-Time Volume Analysis Alerts - newser.com
Sanara MedTech (SMTI): Assessing Valuation After Strategic Shift and Quarterly Earnings Beat - Yahoo Finance
Can Sanara MedTech Inc. stock deliver consistent earnings growth2025 Market Overview & Fast Moving Trade Plans - newser.com
Sanara MedTech Inc. (NASDAQ:SMTI) Q3 2025 Earnings Call Transcript - MSN
Sanara MedTech (SMTI) Is Down 23.5% After Q3 Loss and THP Exit – Has the Investment Case Shifted? - simplywall.st
Visualizing Sanara MedTech Inc. stock with heatmapsJuly 2025 Closing Moves & Reliable Volume Spike Trade Alerts - newser.com
Sanara MedTech Reports Strong Q3 2025 Growth - TipRanks
Identifying reversal signals in Sanara MedTech Inc.2025 Big Picture & Advanced Swing Trade Entry Plans - newser.com
[10-Q] Sanara MedTech Inc. Quarterly Earnings Report | SMTI SEC FilingForm 10-Q - Stock Titan
Sanara MedTech Inc (SMTI) Q3 2025 Earnings Call Highlights: Stro - GuruFocus
Sanara MedTech Inc (SMTI) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - Yahoo Finance
Earnings call transcript: Sanara MedTech Q3 2025 sees revenue growth, stock up 3.1% - Investing.com Nigeria
Sanara MedTech Q3 2025 Earnings Call Transcript - MarketBeat
Sanara MedTech Inc. Initiates Strategic Realignment of its Business, Discontinuing Operations of its Tissue Health Plus - MarketScreener
Sanara MedTech signals strategic shift with THP discontinuation and continued surgical growth focus - MSN
Sanara MedTech Inc. (SMTI) Tops Q3 Earnings Estimates - Yahoo Finance
Sanara Medtech Bets On Core Surgery After Mixed Q3 Results - Finimize
SMTI Posts Strong Q3 Revenue Growth Driven by Surgical Sales - GuruFocus
Medical tech firm Sanara's Q3 revenue misses estimates after Tissue Health Plus unit closure - MarketScreener
Sanara MedTech Inc. Reports Third Quarter 2025 Financial Results (Unaudited) - The Manila Times
[8-K] Sanara MedTech Inc. Reports Material Event | SMTI SEC FilingForm 8-K - Stock Titan
Sanara MedTech to Discontinue Tissue Health Plus Operations After Review - MarketScreener
Sanara MedTech (SMTI) Realigns Focus by Discontinuing THP Operat - GuruFocus
Sanara MedTech discontinues Tissue Health Plus segment - Investing.com
Sanara MedTech Inc. Completes Evaluation of Strategic Alternatives, Discontinues Tissue Health Plus Operations - Quiver Quantitative
Sanara MedTech (NASDAQ: SMTI) to classify THP as discontinued ops, wind-down through 2025 - Stock Titan
What To Expect From Sanara MedTech Inc (SMTI) Q3 2025 Earnings - GuruFocus
Sanara MedTech (SMTI) to Release Earnings on Wednesday - Defense World
Sanara MedTech showcases BIASURGE at TERMIS 2025 in Detroit - Traders Union
Sanara MedTech Inc. stock momentum explainedPortfolio Value Summary & Accurate Intraday Trade Tips - newser.com
What valuation multiples suggest for Sanara MedTech Inc. stockWeekly Investment Report & Entry Point Confirmation Signals - newser.com
1.23%
0.58%
자본화:
|
볼륨(24시간):